Specific FAHFAs have been shown to improve glucose tolerance, enhance insulin sensitivity, and exhibit anti-inflammatory effects, making them potential therapeutic targets for type 2 diabetes (T2D) [5,6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.